Catheter Precision, Inc. Schedule 13G/A amendment discloses that a group of affiliated investment entities and individuals (the "Reporting Persons") report 0% beneficial ownership of the Issuer's common stock, par value $0.0001 per share. The filing identifies the Reporting Persons, their business address, and states the shares reported were held by the Funds.
Positive
None.
Negative
None.
Insights
Filing shows passive, sub-5% holdings with no voting or dispositive power reported.
The amendment lists the Funds, their managers, and two individual managing members, and states 0% ownership and zero sole/shared voting and dispositive power in the cover-page rows referenced. This aligns with a passive, non-controlling reporting posture.
Confirmation items to watch in future filings include any material change to the percentage held or voting/dispositive power; subsequent amendments would reflect such changes.
Key Figures
Par value:$0.0001 per shareCUSIP:74933X708Cover page date:03/31/2026+3 more
6 metrics
Par value$0.0001 per shareCommon Stock par value
CUSIP74933X708Common Stock identifier
Cover page date03/31/2026Cover page entry date
Signature dates05/14/2026Dates signatures were executed
Percent of class0%Percent beneficially owned reported
Voting/Dispositive powers0.00 (sole/shared)Rows 5-8 referenced for voting/dispositive power
"The information required by Item 4(a) is set forth in Row 9 of the cover page"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 0.00 9 0.00"
Schedule 13G/Aregulatory
"Item 1. (a) Name of issuer: Catheter Precision, Inc."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Reporting Personsregulatory
"The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons.""
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Catheter Precision, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
74933X708
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
C/M Capital Master Fund, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
WVP Emerging Manager Onshore Fund LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
C/M Capital Partners, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
Mercer Street Global Opportunity Fund, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
Mercer Street Capital Partners, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
Thomas Walsh
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
74933X708
1
Names of Reporting Persons
Jonathan Juchno
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Catheter Precision, Inc.
(b)
Address of issuer's principal executive offices:
1670 Highway 160 West, Suite 205, Fort Mill, SC 29708
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) C/M Capital Master Fund, LP, a Delaware limited partnership ("C/M Master Fund");
(ii) WVP Emerging Manager Onshore Fund LLC, Delaware limited liability company ("WVP Fund");
(iii) C/M Capital Partners, LP, a Delaware limited partnership ("C/M Capital Partners");
(iv) Mercer Street Global Opportunity Fund, LLC, a Delaware limited liability company ("Mercer Fund," together with C/M Master Fund and WVP Fund, the "Funds");
(v) Mercer Street Capital Partners, LLC, a Delaware limited liability company ("Mercer Capital Partners");
(vi) Thomas Walsh ("Mr. Walsh"); and
(vii) Jonathan Juchno ("Mr. Juchno").
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The shares of common stock, par value $0.0001 per share (the "Common Stock"), of Catheter Precision, Inc. (the "Issuer") reported herein were held by the Funds. C/M Capital Partners is the investment manager to C/M Master Fund and WVP Fund. Mercer Capital Partners is the investment manager to Mercer Fund. Messrs. Walsh and Juchno are the managing members of the general partner of C/M Capital Partners. Mr. Juchno controls Mercer Capital Partners.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 1111 Brickell Ave, Suite 2920, Miami, FL 33131.
(c)
Citizenship:
Each of C/M Master Fund and C/M Capital Partners is a limited partnership organized under the laws of the State of Delaware. Each of WVP Fund, Mercer Fund, and Mercer Capital Partners is a limited liability company organized under the laws of the State of Delaware. Each of Messrs. Walsh and Juchno is a citizen of the United States.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
74933X708
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(b)
Percent of class:
0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
C/M Capital Master Fund, LP
Signature:
/s/ Thomas Walsh
Name/Title:
C/M Global GP, LLC, General Partner, By: Thomas Walsh, Manager
Date:
05/14/2026
WVP Emerging Manager Onshore Fund LLC
Signature:
/s/ Thomas Walsh
Name/Title:
Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
Date:
05/14/2026
C/M Capital Partners, LP
Signature:
/s/ Thomas Walsh
Name/Title:
Thomas Walsh, Partner
Date:
05/14/2026
Mercer Street Global Opportunity Fund, LLC
Signature:
/s/ Jonathan Juchno
Name/Title:
NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
What does Catheter Precision (VTAK) Schedule 13G/A report about ownership?
It reports that affiliated funds and individuals constitute the Reporting Persons and that they hold 0% of common stock. The filing lists entity names, organizational states, and a business address for the Reporting Persons.
Who are the Reporting Persons named in the VTAK Schedule 13G/A amendment?
The filing names C/M Capital Master Fund, WVP Emerging Manager Onshore Fund, C/M Capital Partners, Mercer Street Global Opportunity Fund, Mercer Street Capital Partners, Thomas Walsh, and Jonathan Juchno as Reporting Persons and provides their business address in Miami, FL.
Does the Schedule 13G/A indicate voting or dispositive power for VTAK shares?
No. The amendment states the Reporting Persons have 0.00 sole and shared voting power and 0.00 sole and shared dispositive power as shown in the referenced cover-page rows.
What dates are shown on the Catheter Precision Schedule 13G/A amendment?
The cover information includes an entry date of 03/31/2026 and signature dates of 05/14/2026 for the Reporting Persons and their authorized representatives.
